Skip to content
Home/Companies/Healthcare/Evexta Bio
Evexta Bio

Evexta Bio

Healthcare·France·Active·13yr hold
Entry
2013
Hold
13yr
Status
Active

Who owns Evexta Bio?

Evexta Bio is currently owned by Truffle Capital through Truffle Capital Legacy (pre-2019) (2010 vintage), since 2013.

Hand-verified · updated 2026-06-11

Truffle Capital
Investor
Truffle Capital
Truffle Capital Legacy (pre-2019) · 2010 · VC

Key facts

HQFrance
SectorHealthcare
StatusActive
Websitewww.evextabio.com

More from Truffle Capital Legacy (pre-2019)

Other portfolio companies in the same fund.

Holistick Medical
Holistick Medical
Active
MedTechFrance· 2017
NEW Generation Natural GAS
Active
EnergyFrance· 2017
Pharnext
Exited 2024
SoftwareFrance· 2017
Retency
Exited 2024
SoftwareFrance· 2017
Skinosive
Skinosive
Active
HealthcareFrance· 2017
ACERDE
Acerde
Exited 2021
SoftwareFrance· 2016
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Track Evexta Bio

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Evexta Bio.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue